SEC Form 4 · accession 0001657705-16-000003
SELLAS Life Sciences Group, Inc. · SLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bijan Nejadnik
Officer — Chief Medical Officer
Period of report
Jul 1, 2016
Accepted (ET)
Jul 8, 2016 · 2:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001390478
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2016 | J | 8,503 | $0.3995 | A | 8,503 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to the Issuer's Employee Stock Purchase Plan